Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +11.8% | -9.2% | 1 / 3 | +24.1% | +1.14 pp | -0.56 pp | +16.7% | 0.00 | 4.81 | 412 | +24,1% | 20,9 | +11,8% | 4.81 | 4.98 | −3,3% |
| Pts | 0 | 0 | 4 | 12 | 8 | 4 | 4 | 12 | 8 | |||||||
Valuation annotation:Price: 18.900 (close price on 2026-10-19)EPS (TTM): 3.926
Financial charts
1.Revenue & growth
VND bn412Q2/26
1.Revenue & growth
VND bn412Q2/26
2.Profit & growth
VND bn20,9Q2/26
3.Profit mix (Penman)
VND bn77,5Q2/26
4.Margins & cost structure
%6.8%Q2/26
5.Returns & cash cycle
% · days20.7%Q2/26
6.Earnings quality & cash
VND bn25,7Q2/26
7.Asset structure
VND bn527Q2/26
8.Funding & debt health
VND bn · times527Q2/26
9.Revenue backlog
VND bn9,72Q2/26
10.Valuation
times · %5,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.475Q2/26
Adjusted EPS growth, latest quarter
11.8%
Average adjusted EPS growth, 3 quarters
-9.2%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26